Revvity, Inc. RVTY recently announced that its subsidiary, Immunodiagnostic Systems (“IDS”), received FDA clearance for its ...

The assay enables ChLIA measurement of testosterone markers, delivering diagnostic capabilities for suspected male ...

Chicago, July 31, 2023 (GLOBE NEWSWIRE) -- In the near future, the chemiluminescence immunoassay industry is poised for remarkable growth and innovation. Advances in biotechnology, automation, and ...

The company said the test can measure total testosterone, free testosterone, and sex hormone-binding globulin with an integrated workflow on a single platform.

Dublin, Sept. 15, 2023 (GLOBE NEWSWIRE) -- The "Global Chemiluminescence Immunoassay Market by Product (Instrument, Consumable), Technology (Chemiluminescence Enzyme ...

The ABBOTT PRISM System is an automated immunoassay analyzer designed to perform Chemiluminescent immunoassay (ChLIA) technology. The ABBOTT PRISM performs batch/continuous access and STAT processing ...

Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices ...

Eliminates the need for cold chain logistics, enabling room temperature storage and operation. Reagents remain stable without refrigeration, reducing costs and logistical challenges. Advanced Whole ...

Immunoassays are a valuable tool in industry and the life sciences. These tests are to thank for better disease treatments, safer food and water and advances in biological research. In this guide, we ...

In the PA diagnostic flow chart, the Endocrine Society guidelines recommend that a positive ARR screening should be followed up with one out of four confirmatory tests, to demonstrate that the ...